News | September 19, 2012

ASE Supports CMS Reimbursement Requirements for Cardiac Teams Performing TAVR

September 19, 2012 — Transcatheter aortic valve replacement (TAVR), a minimally invasive treatment for patients with aortic stenosis who are deemed too high-risk for traditional valve replacement surgery, is on the rise. TAVR relies heavily on echocardiography to provide the most accurate view of heart valves, from diagnosis to post-procedure. In response to criticism by physicians about the restrictiveness of conditions put forth by the Center for Medicare and Medicaid Services (CMS) for reimbursement for TAVR, the American Society of Echocardiography (ASE) has emphasized the importance of heart team quality and experience in ensuring positive patient outcomes. 

“ASE supports the emphasis on quality which is embodied in CMS’ decision on TAVR,” noted ASE Advocacy Committee Chair David Wiener, M.D. “The TAVR team approach is in line with the latest guidelines for surgical and percutaneous interventions promulgated by our sister cardiovascular societies, and the concept that specific numbers of procedures must be performed to achieve and maintain competence is one that permeates the medical literature as well as ASE’s own guidelines.”

The "EAE/ASE Recommendations for the Use of Echocardiography in New Transcatheter Interventions for Valvular Heart Disease," a collaborative effort between the ASE and the European Association of Echocardiography (EAE), were published in the September 2011 issue of the Journal of the American Society of Echocardiography (JASE).

As TAVR technology and the skills of those who perform it continue to grow, the requirement that a heart team work in concert to prepare for, perform and monitor the procedure will ensure the best possible outcomes, and TAVR will be an appropriate option for an increasing number of patients.

ASE’s position will be shared with members when a new biannual member publication, Echo, arrives in member mailboxes in mid-September. The new member news source targets members’ need for practical information on practice management, as well as providing a vehicle for news about member activities, association projects and developments in the field of cardiovascular ultrasound.  “Our goal with Echo is to bring relevant information to our members so that they can focus on their patients,” explained ASE President Patricia Pellikka, M.D. “Echocardiography is a valuable and evolving technology, and ASE is constantly seeking new ways to guide our members and this dynamic modality forward.”

Watch the VIDEO “How to Build An Integrated Heart Team.” Brijeshwar Maini, M.D., and Brian Bethea, M.D., from Tenet Florida’s structural heart program, explain the importance of building a good heart team and how that team should interact. 

For more information: www.asecho.org

Related Content

Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | September 11, 2017
September 11, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has sele
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
News | Heart Valve Technology| September 05, 2017
Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a clinical study to...
GE’s blood speckle imaging (BSI) software shows the flow of blood cells’ trajectories. It is a form of blood vector flow imaging.

GE’s blood speckle imaging (BSI) software offers the ability to view a graphical representation of the blood cells’ trajectories.

News | Cardiovascular Ultrasound| September 01, 2017
Cardiologists are constantly on the lookout for new methods to examine the heart using new imaging technology advance
World's First Successful 52-mm Transcatheter Tricuspid Valve Implantation Completed in Italy
News | Heart Valve Technology| August 31, 2017
NaviGate Cardiac Structures Inc. (NCSI) announced that its Gate catheter-guided tricuspid atrioventricular valved stent...
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Sponsored Content | Videos | Cardiovascular Ultrasound| August 30, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Overlay Init